April 6th, 2015
AHA President Elliott Antman discusses the recent scientific statement from the AHA/ACC/ASH on the treatment of hypertension in patients with existing CAD.
September 8th, 2014
This week’s topics include the PARADIGM-HF trial, sham controls in medical-device trials, the efficacy of β blockers in patients with heart failure and atrial fibrillation, and more.
August 18th, 2014
CardioExchange’s Harlan M. Krumholz interviews Sidney C. Smith, coauthor of a new article, published in JACC, that reviews the major findings and recommendations of the 2013 cholesterol guidelines, as well as the recommendations’ implications for risk assessment, LDL lowering, and statin use. Krumholz: How have the new guidelines changed your practice? Smith: The new focus on statins, […]
July 14th, 2014
Harlan Krumholz discusses a JAMA study that found a substantial proportion of Class I guideline recommendations were not durable over a 10-year period.
June 4th, 2014
CardioExchange member Enrique Guadiana asks other physicians whether they’re still happy practicing medicine.
June 2nd, 2014
This week’s topics include the durability of class I ACC/AHA clinical practice guideline recommendations and several papers on hypertension.
March 13th, 2014
The writing committee co-chairs of the 2014 ACC/AHA Valvular Heart Disease Guideline discuss how the committee achieved consensus on the future treatment of valvular disease.
February 6th, 2014
James Stein and Matthew Tattersall discuss why they believe carotid artery IMT testing was incorrectly graded in the 2013 ACC/AHA Guidelines, and tell us what they think the grade should be, and why.
January 27th, 2014
Tell us how you’d determine this 41-year-old African American woman’s 10-year CVD risk, and if you’d put her on a statin.
January 22nd, 2014
A series of clinical vignettes involving decisions affected by the recently published prevention guidelines (JNC 8, ACC/AHA, ESC)